Skip to main content

Peer Review reports

From: Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Original Submission
31 Oct 2011 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
23 Feb 2012 Editorially accepted
23 Feb 2012 Article published 10.1186/1741-7015-10-20

You can find further information about peer review here.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us